Editas Medicine Competitors and Similar CompaniesClear all
Editas Medicine's competitors and similar companies include Biocytogen Boston and Caribou Biosciences.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ||
Founding Date | Founding Date 2013 | Founding Date 2008 | Founding Date 2012 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US | Locations Berkeley, US HQ |
Employees | Employees 20816% increase | Employees 1833% increase | Employees 1477% decrease |
Valuation ($) | Valuation ($) 256.5 m | Valuation ($) N/A | Valuation ($) 174.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $11.2m (FY, 2025) |
Net income | Net income ($160.1m) (FY, 2025) | Net income N/A | Net income ($148.1m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 210m | Total funding raised $ 284.3m | Total funding raised $ 159.5m |
For sources of this data, please see the company profile
View Company Profiles
Biocytogen Boston
HQ
Waltham, US
Biocytogen Boston is a company that provides antibody drug development solutions.
View companyCaribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company